Ki Ho Seol

9PUBLICATIONS
9CO-AUTHORS
Radiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
Quantitative Assessment of Respiratory-Induced Clinical Target Volume Motion During Postoperative Whole-Breast Radiotherapy Using Four-Dimensional Computed Tomography.

|Apr 17, 2025
Trabectedin Induces Synthetic Lethality via the p53-Dependent Apoptotic Pathway in Ovarian Cancer Cells Without BRCA Mutations When Used in Combination with Niraparib.

Bongkyun Kang, Sun-Jae Lee, Ki Ho Seol

|Aug 10, 2024
Assessing the Adequacy of Traditional Vertebral Landmarks as Upper Border of Whole Pelvic Radiotherapy Field for Stage IB2-IIB Cervical Cancer.

Ji Hwan Jo, Jeong Won Lee, Ki Ho Seol

|Aug 06, 2021
Adjuvant Radiotherapy after Surgical Excision in Keloids.

Jeong Won Lee, Ki Ho Seol

|Jun 02, 2021
Pretreatment Neutrophil-to-Lymphocyte Ratio Combined with Platelet-to-Lymphocyte Ratio as a Predictor of Survival Outcomes after Definitive Concurrent Chemoradiotherapy for Cervical Cancer.

Jeong Won Lee, Ki Ho Seol

|Oct 18, 2019
Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy.

Jinju Oh, Ki Ho Seol, Youn Seok Choi

Pageof 2

Frequent Collaborators

4 joint publications

Jeong Won Lee

2 joint publications

Youn Seok Choi

2 joint publications

Ji Hwan Jo

1 joint publications

Hyuk Lee